Which science field has the most promising future?

Computer science
Nanotechnology
Biotechnology
Aerospace engineering
Ecology, resource saving
Cleantech
Other

What is the mankind's most dangerous invention?

Atomic bomb
Drugs
Automobile
Money
Television
Fast food
Internet

Bristol-Myers Squibb funds global R&D in virology; Russian researchers may seek grant support

Bristol-Myers Squibb, a pharmaceutical multinational, has launched Partnering for Cure, a grant program to support R&D in the field of chronic viral disease therapy, including the HIV and B- and C-type chronic hepatitis, Rusnanonet.ru reported.

The company is said to have plans to provide up to 200,000 euro grants for virology research to last as long as two years.

An application for a grant is expected to contain an original and innovative research idea. All applications will be assessed by an international panel of experts representing clinical and scientific circles from several European countries, including Germany, France, Switzerland, Sweden, Belgium, Italy, Spain, and Great Britain.

The applications are due by October 31, 2013, to be submitted through this special website. The experts are expected to make their final decision by November 30, 2013.

There’s been a global tendency lately for an increase in chronic viral diseases. According to World Health Organization (WHO) statistics, about 600,000 people lose their lives each year to the complications of acute or chronic B-type hepatitis. An estimated 150 million people are chronically infected with the C-type hepatitis virus, and as many as 350,000+ patients die annually from virus-associated liver diseases. Two years ago, there were about 34 million people living with the HIV across the planet.

In Russia alone, according to some conflicting expert estimates, there are two-to-five million chronic C-type hepatitis patients and as many as three million suffer from B-type hepatitis. There were 720,014 HIV cases registered in Russia before December 31, 2012. 

2013-09-12, Marchmont News.


Keywords: grants, R&D, funds, pharmaceutical industry

12.09.2013
Bristol-Myers Squibb funds global R&D in virology; Russian researchers may seek grant support
10.09.2013
Smart’ flash memory that tests out radiation
09.09.2013
Stanford University Is Going To Invest In Student Startups Like A VC Firm
06.09.2013
Researchers take a step closer to finding cosmic ray origins
30.08.2013
New research supports theory that life started on Mars
28.08.2013
Siberians develop diagnostics for international nuclear fusion experiment
11.07.2013
Researchers perform DNA computation in living cells
10.07.2013
NeuroMax obtains global rights for new neuropathic pain reliever
10.07.2013
Novosibirsk researchers develop reactor to create human organs in space
09.07.2013
Kickstarting tiny satellites into interplanetary space
08.07.2013
GTF is intended to develop cooperation with Voomy IT-park
08.07.2013
Prostor Capital II Fund will be established in the next year
03.07.2013
Team builds ultrasensitive molybdenum-based image sensor
03.07.2013
Protecting data in the cloud
03.07.2013
Global Innovation Report - not all bad news for Russia

Leave your comment
Sign up
Enter verification codeEnter verification code

Second Moscow International Foreign Investment Forum
Most popular news
Annual Investment Meeting 2013

Welcome to Investment. Innovation. Business Web Portal – a community-driven platform for all the participants of the investment process both in Russia and abroad!

We work to provide online information exchange between Russian and global investors and innovators, business owners and developers.